Cytomegalovirus retinitis in relapsed or refractory low-grade B cell lymphoma patients treated with bendamustine

被引:6
|
作者
Yamasaki, Satoshi [1 ,2 ]
Kohno, Kentaro [1 ,2 ]
Kadowaki, Masanori [1 ,2 ]
Takase, Ken [1 ,2 ]
Iwasaki, Hiromi [1 ,2 ]
机构
[1] Natl Hosp Org Kyushu Med Ctr, Dept Hematol, Chuo Ku, 1-8-1 Jigyohama, Fukuoka 8108563, Japan
[2] Natl Hosp Org Kyushu Med Ctr, Clin Res Inst, Chuo Ku, 1-8-1 Jigyohama, Fukuoka 8108563, Japan
关键词
REACTIVATION;
D O I
10.1007/s00277-017-3005-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1215 / 1217
页数:3
相关论文
共 50 条
  • [31] Bendamustine plus Rituximab as Treatment for Elderly Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
    Vacirca, Jeffrey
    Tabbara, Imad
    Acs, Peter
    Shumaker, Grace
    BLOOD, 2010, 116 (21) : 1157 - 1157
  • [32] Safety and Efficacy of Rituximab Plus Bendamustine in Relapsed or Refractory Diffuse Large B-Cell Lymphoma Patients
    Arcari, Annalisa
    Chiappella, Annalisa
    Valenti, Vanessa
    Zanlari, Luca
    Tani, Monica
    Marasca, Roberto
    Cabras, Maria Giuseppina
    Spina, Michele
    Santagostino, Alberto
    Ilariucci, Fiorella
    Carli, Giuseppe
    Musto, Pellegrino
    Savini, Paolo
    Marino, Dario
    Ghio, Francesco
    Gentile, Massimo
    Cox, Maria Christina
    Della Seta, Roberta
    Vallisa, Daniele
    BLOOD, 2014, 124 (21)
  • [33] Prolonged disease-free survival in relapsed/refractory low-grade lymphoma treated with fludarabine: a report of four cases
    Sternberg, AJ
    Matutes, E
    Killick, S
    Wotherspoon, AC
    Catovsky, D
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (02) : 532 - 534
  • [34] Efficacy and toxicity of bendamustine in patients with relapsed low-grade non-Hodgkin's lymphomas
    Heider, A
    Niederle, N
    ANTI-CANCER DRUGS, 2001, 12 (09) : 725 - 729
  • [35] Cytomegalovirus retinitis and low-grade non-Hodgkin's lymphoma: Case report and review of the literature
    Derzko-Dzulynsky, LA
    Berger, AR
    Berinstein, NL
    AMERICAN JOURNAL OF HEMATOLOGY, 1998, 57 (03) : 228 - 232
  • [36] BENDAMUSTINE PLUS RITUXIMAB FOR RELAPSED OR REFRACTORY DIFFUSE LARGE B CELL LYMPHOMA: A RETROSPECTIVE STUDY
    Merchionne, F.
    Quintana, G.
    Minoia, C.
    Guarini, A.
    Galise, I.
    Quarta, G.
    Loseto, G.
    Melpignano, A.
    HAEMATOLOGICA, 2014, 99 : 696 - 697
  • [37] Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a retrospective analysis
    Merchionne, Francesca
    Quintana, Giovanni
    Gaudio, Francesco
    Minoia, Carla
    Specchia, Giorgina
    Guarini, Attilio
    Quarta, Giovanni
    Pavone, Vincenzo
    Melpignano, Angela
    LEUKEMIA RESEARCH, 2014, 38 (12) : 1446 - 1450
  • [38] Low-Grade Cutaneous B-cell Lymphoma in African American Patients
    Geller, Shamir
    Pulitzer, Melissa
    Myskowski, Patricia L.
    Kheterpal, Meenal
    JOURNAL OF DRUGS IN DERMATOLOGY, 2018, 17 (12) : 1334 - 1337
  • [39] Erratum: Prolonged lymphocytopenia after bendamustine therapy in patients with relapsed or refractory indolent B-cell and mantle cell lymphoma
    H Saito
    D Maruyama
    A M Maeshima
    S Makita
    H Kitahara
    K Miyamoto
    S Fukuhara
    W Munakata
    T Suzuki
    Y Kobayashi
    H Taniguchi
    K Tobinai
    Blood Cancer Journal, 2017, 7 : e620 - e620
  • [40] Romidepsin-Bendamustine Combination for Relapsed/Refractory T Cell Lymphoma
    Nachmias, Boaz
    Shaulov, Adir
    Lavie, David
    Goldschmidt, Neta
    Gural, Alexander
    Saban, Revital
    Lebel, Eyal
    Gatt, Moshe E.
    ACTA HAEMATOLOGICA, 2019, 141 (04) : 216 - 221